Recently, microarray analyses of tumors from ovarian cancer patients at greater biobehavioral risk (i.e., high depression and low social support) revealed an upregulation of MCP1 (reported as CCL2) gene expression. This evidence concerns the gene CCL2 and ovarian carcinoma.